Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,258 public trials 1,193 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Completed

2nd Line Erlotinib Treatment With (Out) Chemotherapy of Advanced Non Small Cell Lung Cancer (NSCLC)

NCT00835471

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Jeroen Bosch Ziekenhuis 's-Hertogenbosch, Netherlands
  • VU medisch centrum Amsterdam, Netherlands
  • Rode Kruis Ziekenhuis Beverwijk, Netherlands
  • Amphia Ziekenhuis Breda, Netherlands
View all 14 locations
View Trial Details
Completed

Paclitaxel-Carboplatin-Bevacizumab +/- Nitroglycerin in Metastatic Non-Squamous-Non-Small Cell Lung Cancer

NCT01171170

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Jeroen Bosch Ziekenhuis 's-Hertogenbosch, Netherlands
  • VU medisch centrum Amsterdam, Netherlands
  • Amphia Ziekenhuis Breda, Netherlands
  • Catharina-Ziekenhuis Eindhoven, Netherlands
View Trial Details
Completed

Pemetrexed Disodium With or Without Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV or Recurrent Non-Small Cell Lung Cancer

NCT00950365

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, +19 more
Locations
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • University of Massachusetts Memorial Health Care Worcester, Massachusetts, United States
  • Albert Einstein College of Medicine The Bronx, New York, United States
  • Bronx River Medical Associates PC The Bronx, New York, United States
View Trial Details
Completed

A Study of Personalized Neoantigen Cancer Vaccines

NCT03794128

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +25 more
Locations
  • University of Chicago Medicine Comprehensive Cancer Center Chicago, Illinois, United States
  • Columbia University Medical Center, Herbert Irving Comprehensive Cancer Center New York, United States
  • The Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
  • Tennessee Oncology Nashville, Tennessee, United States
View Trial Details
Completed

A Study of Abemaciclib (LY2835219) in Combination With Another Anti-cancer Drug in Participants With Lung Cancer (NSCLC)

NCT02079636

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • UCLA Department of Medicine-Hematology/Oncology Los Angeles, California, United States
  • University of California, Davis - Health Systems Sacramento, California, United States
  • Indiana Cancer Pavilion Indianapolis, Indiana, United States
View Trial Details
Completed

A Study of Carboplatin and Pemetrexed Plus Demcizumab (OMP-21M18) in Subjects With Non-Squamous Non-Small Cell Lung Cancer

NCT01189968

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations
  • Royal Brisbane & Women's Hospital Herston, Queensland, Australia
  • Ashford Cancer Centre Research Kurralta Park, South Australia, Australia
  • Monash Medical Centre Clayton, Victoria, Australia
  • Sir Charles Gairdner Hospital Nedlands, Western Australia, Australia
View Trial Details

Related conditions